Portola Pharmaceuticals Inc  

(Public, NASDAQ:PTLA)   Watch this stock  
Find more results forPTLA
38.51
-0.85 (-2.16%)
Apr 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 38.16 - 39.75
52 week 19.59 - 43.63
Open 39.41
Vol / Avg. 138,935.00/407,308.00
Mkt cap 1,974.12M
P/E     -
Div/yield     -
EPS -3.19
Shares 51.26M
Beta     -
Inst. own 91%
May 11, 2015
Q1 2015 Portola Pharmaceuticals Inc Earnings Release (Estimated) - 9:30am GMT-4 - Add to calendar
Mar 3, 2015
Portola Pharmaceuticals Inc at Cowen Health Care Conference
Mar 2, 2015
Q4 2014 Portola Pharmaceuticals Inc Earnings Release
Mar 2, 2015
Q4 2014 Portola Pharmaceuticals Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -1627.53% -1424.67%
Operating margin -1627.69% -1429.26%
EBITD margin - -1413.24%
Return on average assets -45.24% -36.95%
Return on average equity -56.53% -42.58%
Employees 99 -
CDP Score - -

Address

270 East Grand Avenue, Suite 22
SOUTH SAN FRANCISCO, CA 94080
United States - Map
+1-650-2446864 (Phone)
+1-650-2467376 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Portola Pharmaceuticals, Inc. (Portola) is a biopharmaceutical company developing product candidates that have the potential to represent advances in the fields of thrombosis and hematology. The Company is advancing its three wholly owned programs using biomarker and genetic approaches.

Officers and directors

Charles J. Homcy M.D. Co-Chairman of the Board
Age: 65
Bio & Compensation  - Reuters
Hollings C. Renton III Independent Co-Chairman of the Board
Bio & Compensation  - Reuters
William Lis Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Mardi C. Dier Chief Financial Officer, Executive Vice President
Age: 49
Bio & Compensation  - Reuters
John T. Curnutte M.D. Ph.D. Executive Vice President - Research & Development
Age: 63
Bio & Compensation  - Reuters
Peter Strumph Vice President - Technical and Clinical Operations
Bio & Compensation  - Reuters
Laura A. Brege Director
Age: 57
Bio & Compensation  - Reuters
Dennis M. Fenton Ph.D. Director
Age: 63
Bio & Compensation  - Reuters
John H. Johnson Director
Bio & Compensation  - Reuters
Jeffrey W. Bird M.D., Ph.D. Independent Director
Age: 54
Bio & Compensation  - Reuters